ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Economics"

  • Abstract Number: 1003 • 2013 ACR/ARHP Annual Meeting

    Measuring Economic Value of Morning Stiffness; Consistency Over 1 Year

    Risto Tuominen, Public Health, University of Turku, Turku, Finland

    Background/Purpose: Economic evaluation of health care activities requires often measuring clinical symptoms and their changes also in monetary terms. Patients with rheumatoid arthritis (RA) may…
  • Abstract Number: 1004 • 2013 ACR/ARHP Annual Meeting

    Cost-Effectiveness Analysis Of Two Rituximab Based Therapeutic Regimens For Longstanding Rheumatoid Arthritis

    Luca Quartuccio1, Rossella Di Bidino2, Matteo Ruggeri3, Domenico Biasi4, Franco Schiavon5, Leonardo Punzi6, Silvano Adami7, Americo Cicchetti3 and Salvatore De Vita8, 1Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, 2HTA Unit, “A.Gemelli” Teaching Hospital, Rome, Italy, 3Faculty of Economics, Catholic University of the Sacred Heart, Rome, Italy, 4Rheumatology Clinic, University of Verona, Verona, Italy, 5Rheumatology Clinic, University of Padova, Padova, Italy, 6University of Padova, Rheumatology Unit, Padova, Italy, 7Rheumatology Department, University of Verona, Verona, Italy, 8Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy

    Background/Purpose: socioeconomic costs of rheumatoid arthritis (RA) are very high. Biologic therapies with different biologic targets are now available for moderate to severe RA, and…
  • Abstract Number: 1008 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Analysis Of Direct Medical Costs For Systemic Sclerosis Patients: A Population-Based Study

    Natalie McCormick1, Carlo A. Marra2, Eric C. Sayre3 and J. Antonio Avina-Zubieta4, 1Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 2Pharm Sciences, Univ of British Columbia, Vancouver, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada

    Background/Purpose: Patients with systemic sclerosis (SSc) have considerable morbidity which may be associated with high health resource utilization.  Studies on health use and costs are…
  • Abstract Number: 827 • 2013 ACR/ARHP Annual Meeting

    Cost-Effectiveness and Cost-Utility Of a One-Year Coaching Program For Healthy Physical Activity In Rheumatoid Arthritis

    Nina Brodin1,2, Malin Lohela Karlsson3, Emma Swärdh2 and Christina H. Opava4, 1Department of Orthopaedics, Division of Physiotherapy, Dandeyd Hospital, Stockholm, Sweden, 2Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, SE 14183 Huddinge, Sweden, 3Institute of Environmental Medicine (IMM), Intervention and Implementation Research Unit, Karolinska Institutet, Stockholm, Sweden, 4Neurobiology, Care Sciences and Society, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden

    Background/Purpose: Economic evaluations of interventions, as a complement to the effect evaluation, intend to inform decision makers about whether an intervention provides good value for…
  • Abstract Number: 379 • 2013 ACR/ARHP Annual Meeting

    Osteoporotic Fracture and Post-Operative Clinical and Cost Outcomes In Rheumatoid Arthritis: Results From Two UK Inception Cohorts

    Elena Nikiphorou1, Lewis Carpenter2, Josh Dixey3, Peter Williams4, Patrick D. Kiely5, David Walsh6, Richard Williams7 and Adam Young8, 1Research Department of Epidemiology & Public Health, UCL and Rheumatology Department, St Albans City Hospital, ERAS, St Albans City Hospital & University College London (UCL), London, United Kingdom, 2Centre for Lifespan & Chronic Illness Research, University of Hertfordshire, Hatfield, United Kingdom, 3Rheumatology, New Cross Hospital, Wolverhampton, United Kingdom, 4Rheumatology, Medway Maritime Hospital, Gillingham, United Kingdom, 5Rheumatology Dept, St George's Hospital, London, United Kingdom, 6Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom, 7Rheumatology, County Hospital, Hereford, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose:   The risk of osteoporotic fracture is known to be high in RA.  Yet less is known about RA related predictive factors for this…
  • Abstract Number: 60 • 2012 ACR/ARHP Annual Meeting

    The Burden of Early Arthritis in Latin America: Utility Analysis Using Patient-Level Data From the Argentinian Consortium for Early Arthritis

    Christian A. Waimann1, Gustavo Citera2, Hernan Maldonado Ficco3, Oscar L. Rillo4, Mariana Benegas5, Rafael Chaparro del Moral6, Antonio Catalan Pellet7, Anastasia Secco8, Lucila Marino9, Alberto Berman10, Horacio Berman10, Ana Lucía Barbaglia11, Juan Carlos Marcos12, Josefina Marcos13, Francisco Caeiro14, Maria Haye Salinas15, Ana C. Alvarez16, Enrique Soriano17, Zaida Bedran18, Sergio Paira19, Federico Ceccato19, Gabriela Salvatierra20, Ana Quinteros21, Emilio Buschiazzo22 and Edson Javier Velozo23, 1Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 4Rheumatology, Hospital General de Agudos "Dr. E. Tornú", Buenos Aires, Argentina, 5Rheumatology, Hospital Tornu, Buenos Aires, Argentina, 6Rheumatology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 7Rheumatology, Hospital Rivadavia, Buenos Aires, Argentina, 8Rheumathology, Hospital Bernardino Rivadavia, Buenos aires, Argentina, 9Rheumathology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 10Centro Medico Privado de Reumatologia, Tucuman, Argentina, 11Rheumatology, Hospital Padilla, Tucuman, Argentina, 12Rheumatology, Hospital San Martin, La Plata, Argentina, 13Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 14Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 15Reumatología, Hospital Privado de Córdoba, Córdoba, Argentina, 16Rheumatology, Hospital Privado, Córdoba, Argentina, 17Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 18Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 19Rheumatology, Hospital Jose Maria Cullen, Santa Fe, Argentina, 20Rheumatology, Centro de enfermedades Reumaticas, Santiago Del Estero, Argentina, 21Centro Integral de Reumatología, Tucumán, Argentina, 22Rheumatology, Hospital Señor del Milagro, Salta, Argentina, 23Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina

    Background/Purpose: Rheumatoid arthritis (RA) is estimated to be one of the leading causes of non-fatal burden in the world. However, data from developing countries including…
  • Abstract Number: 2646 • 2012 ACR/ARHP Annual Meeting

    Cost-Effectiveness of Tai Chi Mind-Body Exercise for the Treatment of Fibromyalgia

    John B. Wong1 and Chenchen Wang2, 1Medicine/Clinical Decision Making, Tufts Medical Center, Boston, MA, 2Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose:   Although fibromyalgia is associated with substantial annual direct medical and indirect productivity costs, the cost-effectiveness of treatments for fibromyalgia remains understudied. A randomized…
  • Abstract Number: 270 • 2012 ACR/ARHP Annual Meeting

    Use of Drug Combinations in Patients with Osteoarthritis: A Population-Based Cohort Study

    Daniel Prieto-Alhambra1 and Rosa Morros2, 1Internal Medicine; Primary Care; NDORMS Dept; MRC Lifecourse Epidemiology Unit, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol; University of Oxford; University of Southampton, Barcelona, Spain, 2Primary Care, IDIAP Jordi Gol; Institut Català de la Salut, Spain

    TITLE: "Use of drug combinations in patients with osteoarthritis: a population-based cohort study."Background/Purpose: Patients affected with osteoarthritis (OA) use different drugs in search for relief.…
  • Abstract Number: 386 • 2012 ACR/ARHP Annual Meeting

    Costs of Tumor Necrosis Factor Blockers Per Treated Rheumatoid Arthritis Patient Using Real-World Drug Data in a US Managed Care Population

    Vernon F. Schabert1, Crystal Watson2, George Joseph2, Paige Iversen1, Chakkarin Burudpakdee1 and David J. Harrison2, 1IMS Health, Alexandria, VA, 2Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Etanercept (ETN), adalimumab (ADA), and infliximab (INF) are FDA-approved tumor necrosis factor (TNF)-blocker treatments for moderate to severe rheumatoid arthritis (RA) and are commonly…
  • Abstract Number: 717 • 2012 ACR/ARHP Annual Meeting

    Results From a Multi-Tiered Item Collection On Linking Systemic Sclerosis to the International Classification of Functioning, Disability and Health: A EULAR Scleroderma Trials and Research Initiative

    Lesley Ann Saketkoo1, Reuben Escorpizo2, Kevin J. Keen3, Kim Fligelstone4 and Oliver Distler5, 1LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, 2ICF Research Branch in cooperation with the WHO Collaborating Centre for the Family of International Classifications in Germany (DIMDI), Nottwil, Switzerland, 3Mathematics and Statistics, University of Northern British Columbia, Prince George, BC, Canada, 4Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, 5Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Systemic Sclerosis (SSc) affects multiple organs with complex combinations of disability. Skin fibrosis, ischemic pain, ulceration, arthritis, joint contractures, myopathy and cardiopulmonary, renal as…
  • Abstract Number: 910 • 2012 ACR/ARHP Annual Meeting

    The Cost-Effectiveness of Total Joint Arthroplasty: A Systematic Review of Published Literature

    Meghan E. Daigle1, Alexander M. Weinstein1, Jeffrey N. Katz2 and Elena Losina1, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Utilization of total hip arthroplasty (THA) and total knee arthroplasty (TKA) has nearly doubled in the last decade.  These procedures are increasingly performed in…
  • Abstract Number: 918 • 2012 ACR/ARHP Annual Meeting

    Impact of Comorbidities On Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Kossar Hosseini1, Cécile Gaujoux-Viala2, Joel Coste3, Jacques Pouchot1, Bruno Fautrel4, Anne-Christine Rat5 and Francis Guillemin1, 1Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, F- 54 000, France, Nancy, France, 2Rheumatology, Montpellier I University, Nîmes University Hospital, Nîmes, France, 3Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, 4Rheumatology, UPMC - Paris 6 University, Paris, France, 5Université de Lorraine, Nancy, F-54000, France; Inserm, CIC-EC CIE6, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France

    Background/Purpose: Comorbidities refer to chronic co-occuring disorders and are inversely and negatively correlated with HRQoL. Because indirect utility measurement involves HRQoL, comorbidities probably affect utility…
  • Abstract Number: 1816 • 2012 ACR/ARHP Annual Meeting

    Relationship Between Race, Uric Acid Levels, Urate-Lowering Therapy and Resource Use in Patients with Gout

    Kim Coley1, Melissa Saul2 and Karen Pater1, 1Pharmacy & Therapeutics, University of Pittsburgh, Pittsburgh, PA, 2Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Gout is a chronic inflammatory disease caused by the deposition of monosodium urate crystals in joints and soft tissues. The overall prevalence is increasing…
  • Abstract Number: 1815 • 2012 ACR/ARHP Annual Meeting

    Factors Associated with a Prolonged Hospital Length of Stay for Patients with Acute Gout

    Rebecca Sharim1, Meghan Musselman2 and Marissa Blum3, 1Department of Medicine, Temple University Hospital, Philadelphia, PA, 2Temple University School of Medicine, Philadelphia, PA, 3Medicine/Rheumatology, Temple University School of Medicine, Philadelphia, PA

    Background/Purpose: Management of gout in the hospital setting has been poor.  This study aimed to describe patient characteristics and the treatment patterns of acute gout…
  • Abstract Number: 1812 • 2012 ACR/ARHP Annual Meeting

    A Retrospective Evaluation of the Clinical and Economic Implications of Gout in Nursing Home Residents in Hawaii Treated with Allopurinol

    Joy Higa1, Gregory Reardon2 and Gregory Tong3, 1Long Term Care Research Center, Kaneohe, HI, 2Informagenics, LLC, Worthington, OH, 3Takeda Pharmaceuticals America, Inc., Deerfield, IL

    Background/Purpose: We describe patient characteristics, serum uric acid (sUA) levels while on allopurinol, and activities of daily living (ADL) in nursing home residents with gout.…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.